"Acting Attorney General Todd Blanche announced the decision in a post on X, noting that the DOJ would immediately move state-licensed marijuana and FDA-approved marijuana products to Schedule III alongside Tylenol with codeine, ketamine, and steroids."
"Under the decisive leadership of @POTUS, this Department of Justice is delivering on his promise to improve American healthcare. These actions will enable more targeted, rigorous research into marijuana's safety and efficacy, expanding patients' access to treatments and empowering doctors to make better-informed healthcare decisions."
"The DOJ's move to reclassify some forms of marijuana pick up where the Biden administration left off, pushing the broader reclassification process forward."
The Trump administration announced a significant reclassification of certain marijuana forms, moving them from Schedule I to Schedule III. This change indicates a shift in perception, as Schedule III drugs are considered to have a moderate to low potential for abuse. Acting Attorney General Todd Blanche emphasized that this decision will enhance research into marijuana's safety and efficacy, improving patient access to treatments. The DOJ plans to expedite hearings for potential full rescheduling, continuing the reclassification efforts initiated by the Biden administration.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]